178 related articles for article (PubMed ID: 27586194)
1. Cardiac allograft vasculopathy in Dutch heart transplant recipients.
Galli G; Caliskan K; Balk AH; van Domburg R; Birim O; Salerno-Uriarte J; Manintveld OC; Constantinescu AA
Neth Heart J; 2016 Dec; 24(12):748-757. PubMed ID: 27586194
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
[TBL] [Abstract][Full Text] [Related]
3. Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention.
Agarwal S; Parashar A; Kapadia SR; Tuzcu EM; Modi D; Starling RC; Oliveira GH
JACC Heart Fail; 2014 Jun; 2(3):281-8. PubMed ID: 24952696
[TBL] [Abstract][Full Text] [Related]
4. Cardiac allograft vasculopathy in pediatric heart transplant recipients does early-onset portend a worse prognosis?
Khoury M; Conway J; Gossett JG; Edens E; Soto S; Cantor R; Koehl D; Barnes A; Exil V; Glass L; Kirklin JK; Zuckerman WA
J Heart Lung Transplant; 2022 May; 41(5):578-588. PubMed ID: 35172937
[TBL] [Abstract][Full Text] [Related]
5. Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients.
Kobayashi D; Du W; L'ecuyer TJ
Pediatr Transplant; 2013 Aug; 17(5):436-40. PubMed ID: 23714284
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cardiac allograft vasculopathy in heart and heart-lung transplantations: a 15-year retrospective study.
Guihaire J; Mercier O; Flécher E; Aymami M; Fattal S; Chabanne C; Leroy Ladurie F; Lelong B; Cerrina J; Langanay T; Mussot S; Fabre D; De Latour B; Corbineau H; Verhoye JP; Dartevelle P; Leguerrier A; Fadel E
J Heart Lung Transplant; 2014 Jun; 33(6):636-43. PubMed ID: 24630860
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
[TBL] [Abstract][Full Text] [Related]
8. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
[TBL] [Abstract][Full Text] [Related]
9. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
Johansson I; Andersson R; Friman V; Selimovic N; Hanzen L; Nasic S; Nyström U; Sigurdardottir V
BMC Infect Dis; 2015 Dec; 15():582. PubMed ID: 26703239
[TBL] [Abstract][Full Text] [Related]
11. Delayed occurrence of cardiac allograft vasculopathy in Chinese heart transplant recipients compared with their western counterparts.
Wang HJ; Ko WJ; Leea CM; Hsu RB; Chou NK; Wang SS; Liau CS; Chu SH; Lee YT
Clin Transplant; 2004 Feb; 18(1):21-7. PubMed ID: 15108767
[TBL] [Abstract][Full Text] [Related]
12. Cardiac allograft vasculopathy and survival in pediatric heart transplant recipients transitioned to adult care.
Rodenas-Alesina E; Aleksova N; Stubbs M; Foroutan F; Kozuszko S; Posada JD; McDonald M; Moayedi Y; Ross H; Dipchand A
J Heart Lung Transplant; 2024 Feb; 43(2):229-237. PubMed ID: 37704160
[TBL] [Abstract][Full Text] [Related]
13. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
[TBL] [Abstract][Full Text] [Related]
14. Risk Stratification for Cardiac Allograft Vasculopathy in Heart Transplant Recipients - Annual Intravascular Ultrasound Evaluation.
Sato T; Seguchi O; Ishibashi-Ueda H; Yanase M; Okada N; Kuroda K; Hisamatsu E; Sunami H; Watanabe T; Nakajima S; Wada K; Hata H; Fujita T; Fukushima N; Kobayashi J; Nakatani T
Circ J; 2016; 80(2):395-403. PubMed ID: 26701183
[TBL] [Abstract][Full Text] [Related]
15. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
[TBL] [Abstract][Full Text] [Related]
16. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.
Tremblay-Gravel M; Racine N; de Denus S; Ducharme A; Pelletier GB; Giraldeau G; Liszkowski M; Parent MC; Carrier M; Fortier A; White M
JACC Heart Fail; 2017 Dec; 5(12):891-901. PubMed ID: 29191295
[TBL] [Abstract][Full Text] [Related]
17. Non-immune risk predictors of cardiac allograft vasculopathy: Results from the U.S. organ procurement and transplantation network.
Fluschnik N; Geelhoed B; Becher PM; Schrage B; Brunner FJ; Knappe D; Bernhardt AM; Blankenberg S; Kobashigawa J; Reichenspurner H; Schnabel RB; Magnussen C
Int J Cardiol; 2021 May; 331():57-62. PubMed ID: 33571561
[TBL] [Abstract][Full Text] [Related]
18. Dobutamine stress echocardiography during follow-up surveillance in heart transplant patients: Diagnostic accuracy and predictors of outcomes.
Chirakarnjanakorn S; Starling RC; Popović ZB; Griffin BP; Desai MY
J Heart Lung Transplant; 2015 May; 34(5):710-7. PubMed ID: 25682552
[TBL] [Abstract][Full Text] [Related]
19. Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era - a retrospective study.
Goekler J; Zuckermann A; Kaider A; Angleitner P; Osorio-Jaramillo E; Moayedifar R; Uyanik-Uenal K; Kainz FM; Masetti M; Laufer G; Aliabadi-Zuckermann AZ
Transpl Int; 2018 Aug; 31(8):909-916. PubMed ID: 29577455
[TBL] [Abstract][Full Text] [Related]
20. Retransplant and Medical Therapy for Cardiac Allograft Vasculopathy: International Society for Heart and Lung Transplantation Registry Analysis.
Goldraich LA; Stehlik J; Kucheryavaya AY; Edwards LB; Ross HJ
Am J Transplant; 2016 Jan; 16(1):301-9. PubMed ID: 26274617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
